| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More | Sarah de Crescenzo | 05/29/20 | National |
| Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments | Sarah de Crescenzo | 05/26/20 | San Diego |
| With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection | Frank Vinluan | 05/22/19 | Texas |
| ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists | Sarah de Crescenzo | 05/16/19 | San Diego |
| ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later | Sarah de Crescenzo | 11/29/18 | San Diego |
| CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy | Frank Vinluan | 09/17/18 | San Diego |
| Lilly Licenses Sigilon’s Cell Encapsulation Tech for Diabetes Therapy | Corie Lok | 04/04/18 | Boston |
| Connect Marks 30th Year of Most Innovative New Product Awards | Bruce V. Bigelow | 12/01/17 | San Diego |
| With $114M Injection, Semma Continues Quest for Diabetes Cell Therapy | Corie Lok | 11/30/17 | Boston |
| With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells | David Holley | 06/21/17 | Boston |
| With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding | David Holley | 05/31/17 | Texas |
| ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product | Bruce V. Bigelow | 05/23/17 | San Diego |
| ViaCyte Working with Gore to Improve its Synthetic Pancreas Device | Bruce V. Bigelow | 03/29/17 | San Diego |
| West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More | Alex Lash | 02/05/16 | San Francisco |
| ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics | Bruce V. Bigelow | 02/04/16 | San Diego |
| At Cellular Dynamics, The Beat Goes On Under Fujifilm Ownership | Jeff Buchanan | 11/25/15 | Wisconsin |
| San Diego Innovation and the Top 10 Stories of 2014 | Bruce V. Bigelow | 12/30/14 | San Diego |
| West Coast Biotech Roundup: Nevro, Coherus, Xenon, Rock Health, Etc. | Alex Lash | 11/06/14 | San Francisco |
| West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More | Alex Lash | 10/17/14 | San Francisco |
| Doctors Close to Implanting First Stem-Cell Therapy for Diabetes | Bruce V. Bigelow | 10/10/14 | San Diego |
| West Coast Biotech Roundup: Gates, Orexigen, Medivation & More | Alex Lash | 09/12/14 | Seattle |
| West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More | Alex Lash | 08/28/14 | San Francisco |
| ViaCyte Garners $15,000,000 New Financing | VentureDeal | 08/22/14 | San Diego |
| West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More | Alex Lash | 08/21/14 | San Diego |
| West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More | Alex Lash | 08/14/14 | San Francisco |
| ViaCyte Lands $5,400,000 Series C Funding | VentureDeal | 08/08/14 | San Diego |
| San Diego Life Sciences Roundup: Conatus, ViaCyte, Organovo, and More | Bruce V. Bigelow | 07/11/13 | San Diego |
| ViaCyte Lands $10,600,000 Series C Financing | VentureDeal | 07/10/13 | San Diego |
| California Stem Cell Agency Shifts Focus to Clinical Treatments | Bernadette Tansey | 01/31/13 | San Francisco |
